07 Jan 2001

Cefakliman® (Cefakliman® Tabletten) - Deutschland

Updated: 07 Jan 2001


Klimakterische Ausfallserscheinungen.

Cefakliman® Description, Presentation and Dosage

Cefakliman® Description

Cefakliman® Drug Class Description


Cefakliman® Drug Description

1 Tbl. enth.: Lachesis D12 10 mg, Cimicifuga D5 10 mg, Sepia D5 10 mg, Lilium tigrinum D5 10 mg.

Cefakliman® Generic Name

Cefakliman® Tabletten

Cefakliman® Presentation

Cefakliman® Presentation


Cefakliman® Manufacturer


Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Cefakliman® Dosage

Cefakliman® Adult Dosage

Lactose, Magnesiumstearat.

Cefakliman® Precautions, Reactions and Contraindications

Cefakliman® Special Precautions

Related Drugs - Women's Health and Obs/Gyn

Back to top